Trial Profile
Effects of S 18886 on platelet function in type 2 diabetic patients treated by low-dose aspirin and with elevated levels of thromboxane A2. A multicentre, randomised, double-blind, cross-over study comparing S 18886 30 mg o.d. versus aspirin 100 mg o.d. administered orally.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Terutroban sodium (Primary) ; Aspirin
- Indications Cardiovascular disorders; Embolism and thrombosis
- Focus Biomarker; Therapeutic Use
- Sponsors IRIS
- 05 Aug 2011 New trial record